SEC Form 4 · accession 0001645627-17-000097
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 19, 2017
Accepted (ET)
Jul 24, 2017 · 3:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 19, 2017 | P | 7,000 | $0.0219 | A | 21,778,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.0219 | A | 21,780,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.0219 | A | 21,782,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.0217 | A | 21,784,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.0218 | A | 21,786,019 | D | |
| Common Stock | Jul 19, 2017 | P | 5,000 | $0.0218 | A | 21,791,019 | D | |
| Common Stock | Jul 19, 2017 | P | 10,000 | $0.0215 | A | 21,801,019 | D | |
| Common Stock | Jul 19, 2017 | P | 5,000 | $0.0215 | A | 21,806,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.0215 | A | 21,808,019 | D | |
| Common Stock | Jul 19, 2017 | P | 5,000 | $0.0207 | A | 21,813,019 | D | |
| Common Stock | Jul 19, 2017 | P | 5,000 | $0.0206 | A | 21,818,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.0214 | A | 21,820,019 | D | |
| Common Stock | Jul 19, 2017 | P | 5,000 | $0.0206 | A | 21,825,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.0206 | A | 21,827,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.0215 | A | 21,829,019 | D | |
| Common Stock | Jul 19, 2017 | P | 5,000 | $0.0215 | A | 21,834,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.0218 | A | 21,836,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.022 | A | 21,838,019 | D | |
| Common Stock | Jul 19, 2017 | P | 5,000 | $0.0219 | A | 21,843,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.021 | A | 21,845,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.021 | A | 21,847,019 | D | |
| Common Stock | Jul 19, 2017 | P | 5,000 | $0.021 | A | 21,852,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.021 | A | 21,854,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.0209 | A | 21,856,019 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.021 | A | 21,858,019 | D | |
| Common Stock | Jul 19, 2017 | P | 5,370 | $0.021 | A | 21,863,389 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.021 | A | 21,865,389 | D | |
| Common Stock | Jul 19, 2017 | P | 5,000 | $0.021 | A | 21,870,389 | D | |
| Common Stock | Jul 19, 2017 | P | 2,000 | $0.0219 | A | 21,872,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0216 | A | 21,874,389 | D |
Table II — derivative securities
No Table II lines on this filing.